Share:
Notifications
Clear all
Analytical Procedure Development
1
Posts
1
Users
0
Reactions
22
Views
Apr 18, 2025 12:15 pm
For new modality therapeutics (cell and gene therapy), what would be your recommendations on ECs submission for early-phase (Phase 1/2) programs with low level of prior knowledge?
Share:
Advertisement
Advertisement
Advertisement